Is Ventas (VTR) a risky stock?
As of July 21, 2026, Clavix grades Ventas (VTR) C+ for risk, a composite score of 62 out of 100 on an A+ to F scale, which puts VTR in the "average" band. The grade is a risk read for educational purposes, not a buy or sell recommendation.
Grade as of July 21, 2026. Clavix regrades every trading day.
The five risk dimensions behind VTR's grade
Each Clavix grade is a composite of five independent reads. Higher is safer. Here is how VTR scores on each, as of July 21, 2026.
What's moving VTR's risk right now
Company-specific signals Clavix flags behind VTR's current grade, drawn from recent news and filings as of July 21, 2026.
Union Bancaire Privee bought 33,030 Ventas shares while Patton Fund Management sold 60,624, leaving institutional news signal split. Analysts expect solid Q2 FFO growth, but investors want confirmation against Ventas's own guidance.
Dorsey Wright & Associates raised its Ventas stake by 279.2% in Q1, ending the period with 15,356 shares worth about $1.26 million. The position is small, so it reflects one fund's increased interest rather than a major demand shift.
What a C+ grade means
On the Clavix A+ to F scale, VTR's composite of 62 falls in the C band (50–64), read as "average." The scale is fixed, so the meaning never moves.
This page is generated from Clavix's own risk model and is for educational purposes only. It is not investment advice or a recommendation to buy or sell VTR or any security. Grades are risk indicators, not predictions of return. Data may be delayed.